A patient with moderate persistent asthma uses their short-acting beta-agonist (SABA) more than twice per week. What does this indicate?
-
A
Well-controlled asthma
-
B
Inadequate asthma control requiring step-up therapy
-
C
Normal SABA usage pattern
-
D
The patient should switch to a LABA only